FibroGen Announces Positive Phase 2 Trial Results for Roxadustat, an Anemia Treatment for CKD Patients
News
FibroGen, Inc., announced the publication of positive results from a Phase 2 clinical trial of roxadustat, its drug candidate for the treatment of anemia in patients with chronic kidney disease (CKD), and ... Read more